Robin A. Robinson

Dr. Robinson is a respected authority on the development of breakthrough biomedical technologies, and a seasoned expert in consummating collaborations with leading U.S. government agencies, Fortune 500 companies, academic research groups, and foreign governments, for which he was cited in 2018 as one of the top 100 innovators in medicine by The Medicine Maker. Notably, Dr. Robinson was appointed as the first director of the Biomedical Advanced Research and Development Authority at the U.S. Department of Health and Human Services, managing an annual budget of $1.35 billion and a staff of 250 scientists and medical experts. He brought BARDA into prominence as one of the top 10 fully integrated R&D organizations worldwide supporting advanced development and acquisition of more than 240 drugs, vaccines, diagnostics, and medical devices for man-made biodefense threats, pandemic influenza, and emerging infectious diseases, including Ebola and Zika viruses. Some 32 of these medical countermeasure products were approved and licensed by the U.S. Food and Drug Administration during his 12-year tenure.